RhumbLine Advisers’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $695K | Sell |
|
|||||
|
2025
Q2 | $555K | Buy |
|
|||||
|
2025
Q1 | $306K | Buy |
|
|||||
|
2024
Q4 | $282K | Buy |
|
|||||
|
2024
Q3 | $715K | Sell |
|
|||||
|
2024
Q2 | $993K | Buy |
|
|||||
|
2024
Q1 | $1.57M | Buy |
|
|||||
|
2023
Q4 | $620K | Buy |
|
|||||
|
2023
Q3 | $581K | Sell |
|
|||||
|
2023
Q2 | $911K | Buy |
|
|||||
|
2023
Q1 | $466K | Buy |
|
|||||
|
2022
Q4 | $546K | Buy |
|
|||||
|
2022
Q3 | $825K | Buy |
|
|||||
|
2022
Q2 | $836K | Buy |
|
|||||
|
2022
Q1 | $749K | Buy |
|
|||||
|
2021
Q4 | $1.32M | Buy |
|
|||||
|
2021
Q3 | $1.88M | Buy |
|
|||||
|
2021
Q2 | $469K | Buy |
|
|||||
|
2021
Q1 | $702K | Buy |
|